Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hela_02_GluC

ABSTRACT: Cancer Cell line - Hela 02 Gluc

OTHER RELATED OMICS DATASETS IN: PRJEB2718

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Others

SUBMITTER: Nagaraj N, Wisniewski JR, Geiger T, Cox J, Kircher M, Kelso J, P��bo S, Mann M

PROVIDER: PAe003654 | PeptideAtlas | 2011-12-31

REPOSITORIES: PeptideAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	PAe003654_7167_tandem.params	Other
	PAe003654_README	Other
	PAe003654_Search_Results_7167_201211201640.properties	Other
	PAe003654_Search_Results_7167_201211201640.tar.gz	Other
	PAe003654_mzML_201211201354.properties	Other

Items per page:

1 - 5 of 9

Publications

Deep proteome and transcriptome mapping of a human cancer cell line.

Nagaraj Nagarjuna N Wisniewski Jacek R JR Geiger Tamar T Cox Juergen J Kircher Martin M Kelso Janet J Pääbo Svante S Mann Matthias M

Molecular systems biology 20111108

While the number and identity of proteins expressed in a single human cell type is currently unknown, this fundamental question can be addressed by advanced mass spectrometry (MS)-based proteomics. Online liquid chromatography coupled to high-resolution MS and MS/MS yielded 166 420 peptides with unique amino-acid sequence from HeLa cells. These peptides identified 10 255 different human proteins encoded by 9207 human genes, providing a lower limit on the proteome in this cancer cell line. Deep t ...[more]

PMID: 22068331

Similar Datasets

Hela_02_Lysc

Project description:Cancer Cell line - Hela 02 Lysc

2011-12-31 | PAe003658 | PeptideAtlas

Hela_02_trypsin

Project description:Cancer Cell line - Hela 02 trypsin

2011-12-31 | PAe003653 | PeptideAtlas

Hela_01_GluC

Project description:Cancer Cell line - Hela 01 Gluc

2011-12-31 | PAe003651 | PeptideAtlas

Homo sapiens

Project description:Cell division cycle in a human cancer cell line (HeLa)

| PRJNA93325 | ENA

Project description:Human HeLa cell line transcriptome

| PRJNA791826 | ENA

Enhanced anti-cancer effects of conditioned medium from hypoxic human adult dermal fibroblasts on cervical cancer cells [dataset 2]

Project description:Hypoxia regulates fibroblast function by changing intracellular signaling and secretion factors, which influences the states of nearby cells. In this work, we investigated the effects of conditioned medium (CM) from human adult dermal fibroblasts (HDFs) cultured in normoxic and hypoxic conditions on cervical cancer (HeLa) cells. The HeLa cells showed decreased cell viability, in-creased apoptosis, and cell cycle arrest in response to CM from hypoxic-cultured HDFs (H-CM) compared with CM from normoxic-cultured HDFs (N-CM). Among the proteins up-regulated (> 2-fold) in H-CM compared with N-CM, LTBR decreased the viability of HeLa cells. Among the intracellular proteins down-regulated (> 2-fold) in HeLa cells treated with H-CM compared with N-CM, the most enriched biological process GO term and KEGG pathway were protein deubiq-uitination and hsa05166:HTLV-I infection, respectively. In the protein–protein interaction net-work of intracellular proteins with altered expression (> 2-fold), 1 up-regulated (TNF) and 8 down-regulated (ESR1, MCL1, TBP, CD19, LCK, PCNA, CHEK1, and POLA1) hub proteins were defined. Among the down-regulated hub proteins, the most enriched biological process GO term and KEGG pathway were leading strand elongation and hsa05166:HTLV-I infection, respectively. This study reveals that H-CM had enhanced anti-cancer effects on cervical cancer cells compared with N-CM, and it induced intracellular signaling patterns related to those enhanced anti-cancer effects.

2022-03-04 | GSE185979 | GEO

Enhanced anti-cancer effects of conditioned medium from hypoxic human adult dermal fibroblasts on cervical cancer cells [dataset 1]

2022-03-04 | GSE185978 | GEO

Genetic profiling of HNC cell lines

Project description:We performed gene expression profiling of 39 head and neck cancer cell lines and 1 hela cell line, and classified them based on previous classification of head and neck squamous cell tumors from patients We performed gene expression profiling of 39 head and neck cancer cell lines and 1 hela cell line.

2015-09-01 | E-GEOD-52088 | biostudies-arrayexpress

Immunopeptidomics DIA and DDA Dynamic Range Experiment

Project description:The peptide identification sensitivity of the affinity purified immunopeptidome of a JY cell line (Epstein–Barr virus-immortalized B cell lymphoblastoid line, ECACC 94022533, IHW9287) for DDA and DIA experiments was assessed by a linear concentration series. JY cells are homozygous for all HLA-I loci (HLA-A*02:01, HLA-B*07:02, and HLA-C*07:02). The JY HLA-I ligandome was isolated through immunoaffinity purification, as described in Marcu, Bichmann and Kuchenbecker et al 2021.

2025-09-04 | PXD024809 | Pride

Expression data from human embryonic kidney cells (HEK293) cultivated in high and low glucose

Project description:Gene expression profiling of human embryonic kidney (HEK293) cells was performed to determine the effect of high and low glucose on gene expression. Microarrays were used to identify distinct classes of genes up-regulated in HEK293 cells during cultivation for 7 days in medium with physiological (low) glucose compared to high glucose. Human embryonic kidney cells (HEK293) were cultivated for 7 days in commercially available DMEM (supplemented with 10 % FCS) containing high glucose (450 mg/dl) or low glucose (100 mg/dl). Cells were harvested, total RNA was extracted and microarray gene expression profiling was performed to compare differential gene expression between low and high glucose conditions. Two biological replicates for each condition were made (high glucose: HEK-high-gluc-1 and HEK-high-gluc-2; and low glucose: HEK-low-gluc-1 and HEK-low-gluc-2).

2009-04-08 | E-GEOD-15575 | biostudies-arrayexpress